Genetic Signatures (ASX:GSS) Operating Cash Flow per Share : A$-0.07 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Operating Cash Flow per Share?

Genetic Signatures's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.02. Genetic Signatures's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.07.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Genetic Signatures's Operating Cash Flow per Share or its related term are showing as below:

ASX:GSS' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -41.1 Med: 4.15 Max: 14.8
Current: -5.2

During the past 9 years, Genetic Signatures's highest 3-Year average Operating Cash Flow per Share Growth Rate was 14.80% per year. The lowest was -41.10% per year. And the median was 4.15% per year.

ASX:GSS's 3-Year OCF Growth Rate is ranked worse than
59.32% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.4 vs ASX:GSS: -5.20

Genetic Signatures Operating Cash Flow per Share Historical Data

The historical data trend for Genetic Signatures's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Operating Cash Flow per Share Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

-0.07

0.03

0.07

-0.09

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial													0.05	0.01	-0.04	-0.05	-0.02

Competitive Comparison of Genetic Signatures's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Genetic Signatures's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Price-to-Operating-Cash-Flow falls into.

Genetic Signatures Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Genetic Signatures's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-12.451	/	146.811
	=	-0.08

Genetic Signatures's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-2.459	/	143.912
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.07

Genetic Signatures Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.